Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly developed form of CRISPR at UNSW Sydney points to a safer way of treating ...

These positive stories—from drops in crime to in environmental progress—help us look to the next year with some degree of ...

The Trump administration’s cuts to research may have spoiled the country’s appetite for bold exploration.

The year 2025, despite chaos and disruption, also witnessed remarkable breakthroughs in health, science, environment, and ...

Brazilian mystic Athos Salomé, 39, has made numerous accurate predictions over the years, including the onset of the ...

Wall Street analysts have painted a tantalizing picture of triple-digit upside potential for some of this year’s worst-performing biotech names. Yet investors may want to temper their excitement.

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe ...